跳至主要内容
临床试验/NCT00162058
NCT00162058已完成2 期

An Open-Label, Non-Randomized, Phase II Trial To Assess Focal Liver Lesion Detection Using Definity-Enhanced Ultrasound Imaging

Lantheus Medical Imaging1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2004年3月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
80
试验地点
1
主要终点
The ratio of signal intensities obtained from unenhanced vs. contrast-enhanced ultrasound imaging of liver tissue and liver lesions will be calculated at the end of the study.

研究概览

简要总结

To determine the optimal dose of DMP 115 to image liver lesions and to assess whether contrast can improve the detection of focal liver lesions.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with 1 but <7 focal liver lesions
  • Scheduled for liver biopsy within 30 days of study
  • Scheduled for CT or MR within 30 days of study

排除标准

  • Critically ill subjects
  • Subjects with right-to-left shunts

结局指标

主要结局

The ratio of signal intensities obtained from unenhanced vs. contrast-enhanced ultrasound imaging of liver tissue and liver lesions will be calculated at the end of the study.

次要结局

  • The determination of the presence or absence of focal liver lesions during the Blinded Read and the Institutional Read of ultrasound images.

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验